Letter to the Editor Archives - Page 2 of 6 - Revista Brasileira de Ginecologia e Obstetrícia

Dear Editor, Syphilis is a sexually-transmitted infection (STI) identified as a public health problem in Brazil and worldwide. According to the World Health Organization (WHO), in 2016, 6.3 million cases of the disease were diagnosed worldwide, with an estimated global prevalence of 0.5%. In Brazil, the disease has come to be considered an epidemic due […]

Dear Editor, The Scimago Journal and Country Rank measures and classifies the journals and country scientific indicators from the information contained in the Scopus database. This portal uses several indicators such as the SJR, defined as “a measure of the impact, influence, or prestige of the journal. It expresses the average number of weighted citations […]

Dear Editor, Iatrogenic operative injuries sustained to the urinary tract are not uncommon during obstetric and gynecological (Obs&Gyn) surgery. The ureters and bladder are usually involved. These injuries are among the most serious complications of Obs&Gyn surgery. About 75% of iatrogenic injuries to the urinary tract are due to Obs&Gyn surgical interventions, whereas injuries to […]

Dear Editor, We would like to share ideas on “We have Vaccine for Covid-19! What to Recommend for Pregnant Women?”1 Quintana1 concluded that “The final decision whether or not to receive the vaccine will be made by the woman after receiving the appropriate information. This same principle applies with even greater emphasis to puerperal and […]

Introduction Obesity is now a major global epidemic. In 2016, 39% of adults worldwide ≥ 18 years old were overweight, and 13% were obese, as reported by the World Health Organization (WHO). This current scenario is compounded in high-income countries such as the United States, where 31% of the population has a body mass index […]

Dear Editor, We read with interest the Clinical Consensus Recommendation about screening and prevention of preeclampsia published by De Oliveira et al. The authors recommend that identification of high-risk women should be based on maternal risk factors alone, and that universal treatment (of all pregnant women) with aspirin at a dose of 100 mg should be […]